BISOLVON 10 MG/G ORAL POWDER
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
22-12-2015
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
BROMHEXINE HYDROCHLORIDE
Inapatikana kutoka:
Boehringer Ingelheim Ltd
ATC kanuni:
QR05CB02
INN (Jina la Kimataifa):
BROMHEXINE HYDROCHLORIDE
Kipimo:
10 mg/g
Dawa fomu:
Oral Powder
Dawa ya aina:
POM
Kundi la matibabu:
Bovine, Canine, Feline, Porcine
Eneo la matibabu:
Bromhexine
Matibabu dalili:
Respiratory Tract Preparations
Idhini hali ya:
Authorised
Idhini ya tarehe:
1991-10-01
Tabia za bidhaa
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bisolvon 10mg/g Oral Powder
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
Active Substance
Bromhexine Hydrochloride
10 mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Powder for oral solution or addition to feed.
White crystalline powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, pigs, dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
As an aid to the treatment of respiratory disease in cattle, pigs, dogs and cats where mucus is a complicating factor.
4.3 CONTRAINDICATIONS
Not for use in cows producing milk for human consumption.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Avoid contact with the skin and eyes. In case of accidental eye contact, flush the affected eye with copious amounts of
clean running water. Wash hands and exposed skin after administering the product.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 07/12/2015_
_CRN 7022423_
_page number: 1_
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Not applicable.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
May be used in conjunction with antibiotics and/or sulphonamides, bronchodilators etc.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For oral administration in the feed or drinking water. Add to feed or drinking water immediately before
administration. Discard any remaining medicated feed or drinki
Soma hati kamili
